The Rise of Surgical Robotics at DeviceTalks West 2025
At the DeviceTalks West and RoboBusiness events held October 15–16, 2025 in Santa Clara, surgical robots became a central theme among medtech industry leaders. Sessions ranged from “Protecting Innovation in Robotics” to deep dives on how AI and robotics are reshaping operating rooms. In particular, Moon Surgical—one of the emerging players in surgical robotics—was featured, with a CTO-led talk on how its Maestro system could overcome staffing shortages while capturing procedural data.
This emphasis matters because it signals a shift: the operating room could soon host AI Employees, Non-Human Workers, and Voice AI Agents not just as futuristic ideas, but as real tools assisting surgeons. The convergence of robotics, edge AI, and integrated data systems suggests a near-term reality for digitally enabled surgery.
What’s New: Moon Surgical’s Maestro and ScoPilot
Moon Surgical’s Maestro system is a two-armed robotic assistant designed for minimally invasive “soft tissue” procedures (e.g. abdominal, gynecologic, urologic). Rather than replacing surgeons, it augments them—serving as a kind of Non-Human Worker that holds instruments, controls the laparoscope, and streamlines coordination in the OR.
A key advance is ScoPilot™, a real-time AI enhancement cleared by the FDA in 2025, which lets Maestro automatically adjust camera view based on instrument motion—so the surgeon doesn’t need to pause or disengage to reposition the visual field. In addition, new FDA clearance now allows Maestro to connect with a cloud platform, Maestro Insights, enabling analytics, scheduling, utilization monitoring, and remote oversight.
Other developments:
- As of mid-2025, Maestro has supported over 1,600 procedures, many in just the past year.
- Maestro has also begun deployment in ambulatory surgery centers (ASCs): 20 patients have been treated across procedures like cholecystectomy and gastric sleeve surgery in a first ASC rollout.
- Moon Surgical is bringing in senior talent to scale commercialization in both the U.S. and Europe.
Why It Matters: Towards Voice AI Agents in the OR
This development is significant for several reasons:
- Workflow efficiency & staffing relief – In environments with surgical staff shortages, AI Employees (robotic assistants) can shoulder tasks like instrument holding and camera control, reducing friction and delays.
- Continuous learning & data feedback – With connectivity to Maestro Insights, non-human workers can generate procedural data, enabling analytics and iterative improvement.
- Towards agentic autonomy – ScoPilot is a step toward Voice AI Agents or autonomous behaviors—anticipating surgeon motions, adjusting views, and reducing the need for manual micromanagement.
- Broader accessibility – By lowering the barrier to robotic assistance in ASCs and standard laparoscopic settings, these systems may democratize high-precision surgery beyond large hospital settings.
Looking ahead, the presence of surgical robots in industry conferences underscores that these systems are moving from experimental novelties to serious actors in healthcare.
Key Highlights:
- DeviceTalks West (Oct 15–16, 2025) spotlighted robotics and AI in surgery.
- Moon Surgical’s Maestro system offers robotic assistance in soft tissue laparoscopic procedures.
- ScoPilot (AI module) enables hands-free camera control, approved by FDA in 2025.
- Maestro now supports cloud connectivity through Maestro Insights for analytics and remote oversight.
- Over 1,600 procedures have used Maestro; rollout includes ambulatory surgery centers.
- These advances mark steps toward fully autonomous assistants and Voice AI Agents in the operating room.
Reference:
https://www.therobotreport.com/surgical-robots-take-center-stage-devicetalks-west-robobusiness/
